Related Experiment Videos

Tracheal resection and reanastomosis in the neonatal period

S Islam1, P T Masiakos, D P Doody

  • 1Department of Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114-2696, USA.

Insights

This study shows that tracheal resection and reanastomosis (TRR) is a safe and successful treatment for neonates with severe congenital tracheal stenosis requiring extracorporeal life support (ECLS). Both infants survived and had no narrowing at the repair site.

Area of Science:

  • Pediatric Surgery
  • Neonatal Respiratory Care
  • Congenital Airway Anomalies

Background:

  • Severe congenital tracheal stenosis is a rare condition often managed conservatively.
  • Surgical repair (tracheal resection and reanastomosis - TRR) has been reported in older infants but not in neonates.
  • Two neonates with life-threatening respiratory failure due to tracheal stenosis required extracorporeal life support (ECLS).

Observation:

  • Both neonates presented with severe respiratory failure and pulmonary hypertension on day one of life.
  • Complex congenital anomalies were present in one patient, including lung agenesis and tracheoesophageal fistula.
  • Surgical repair (TRR) was performed on day 3 and day 7 of life while the patients were on ECLS.

Findings:

  • Both neonates survived the TRR procedure without bleeding complications.
  • Patients were successfully weaned from ECLS post-surgery.
  • Both infants are alive and well at long-term follow-up with no evidence of tracheal narrowing at the repair site.

Implications:

  • Tracheal resection and reanastomosis (TRR) is a viable and safe surgical option for neonates with focal tracheal stenosis and severe respiratory failure.
  • This approach can be successfully implemented in critically ill neonates supported by extracorporeal life support (ECLS).
  • Early surgical intervention may offer a favorable long-term outcome for this rare condition.
Abstract

Related Concept Videos